Skip to content
PulseMS
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer review unconfirmed

MRI Evaluation in MOGAD

A systematic review highlighted the importance of MRI in evaluating MOGAD, revealing characteristic imaging features and lesion behavior that assist in diagnosis. It suggested standardized MRI protocols to enhance clinical use and assist research consistency.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

Understanding MRI's role in MOGAD can improve diagnostic accuracy and promote standardized practices, leading to better patient management.

What this does not prove

The study does not connect to MS efficacy and notes that MOGAD has less clinical utility for routine MRI surveillance due to rare asymptomatic activity.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Systematic review
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-09-28
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified

Original sources

Supporting passages (5)
study designOBSERVATIONS: This article summarizes the hallmark MRI features of optic nerve, brain, and spinal cord involvement in MOGAD, including key findings from the 2023 diagnostic criteria, supported by illustrative figures and detailed tables.
findingsCONCLUSIONS AND RELEVANCE: MRI is central to MOGAD evaluation, and recognition of the characteristic imaging features and lesion dynamics outlined in this review can aid diagnosis.
findingsApplication of the standardized MRI protocol summarized here can optimize use in clinical practice and promote harmonization across research studies.
limitationsThe clinical course of MOGAD is of attack-related neuroinflammation evident clinically and radiologically, and asymptomatic radiological activity is rare, suggesting that surveillance MRI has less clinical utility than in MS and less value as a surrogate biomarker in clinical trials.
publication datePublication date: 2026-09-28

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.